DARPP-32 Polyclonal Antibody
- 货号:YT1291
- 应用:WB;IHC;IF;ELISA
- 种属:Human;Mouse;Rat
- 简介:
- >>cAMP signaling pathway;>>Dopaminergic synapse;>>Cocaine addiction;>>Amphetamine addiction;>>Alcoholism
- 蛋白名称:
- Protein phosphatase 1 regulatory subunit 1B
- 免疫原:
- The antiserum was produced against synthesized peptide derived from human DARPP-32. AA range:41-90
- 特异性:
- DARPP-32 Polyclonal Antibody detects endogenous levels of DARPP-32 protein.
- 组成:
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 来源:
- Polyclonal, Rabbit,IgG
- 稀释:
- WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200
- 纯化工艺:
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 储存:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- 其他名称:
- PPP1R1B;DARPP32;Protein phosphatase 1 regulatory subunit 1B;DARPP-32;Dopamine- and cAMP-regulated neuronal phosphoprotein
- 背景:
- This gene encodes a bifunctional signal transduction molecule. Dopaminergic and glutamatergic receptor stimulation regulates its phosphorylation and function as a kinase or phosphatase inhibitor. As a target for dopamine, this gene may serve as a therapeutic target for neurologic and psychiatric disorders. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011],
- 功能:
- function:Inhibitor of protein-phosphatase 1.,PTM:Dopamine- and cyclic AMP-regulated neuronal phosphoprotein.,PTM:Phosphorylation of Thr-34 is required for activity.,similarity:Belongs to the protein phosphatase inhibitor 1 family.,
- 组织表达:
- Adipose tissue,Brain,Cerebellum,Colon,Ovary,
- Western Blot analysis of various cells using DARPP-32 Polyclonal Antibody diluted at 1:500
- Western Blot analysis of COLO205 cells using DARPP-32 Polyclonal Antibody diluted at 1:500
- Immunohistochemistry analysis of paraffin-embedded human brain tissue, using DARPP-32 Antibody. The picture on the right is blocked with the synthesized peptide.
- Western blot analysis of lysates from 293 cells, treated with EGF 200ng/ml 30', using DARPP-32 Antibody. The lane on the right is blocked with the synthesized peptide.